LoginRegister
    AstraZeneca to sublicense global rights to MovantikAstraZeneca to sublicense global rights to Movantik
    Members are ready to brace up for any shortages in medical equipment: MTaIMembers are ready to brace up for any shortages in medical equipment: MTaI
    Sun Pharma launches RIOMET ER diabetes drug in the USSun Pharma launches RIOMET ER diabetes drug in the US
    Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreakEnsure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19...
    Sourav Ganguly becomes the brand Ambassador for Piramals antacid PolycrolSourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol
    USFDA inspection at Cipla manufacturing facility in Goa, warning letter issuedUSFDA inspection at Cipla manufacturing facility in Goa, warning letter issued
    APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01
    COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodiesCOVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of...
    USFDA identifies 20 drugs with shortage risks due to coronavirus outbreakUSFDA identifies 20 drugs with shortage risks due to coronavirus outbreak
    Sanofi plans to create standalone company dedicated to making APIsSanofi plans to create standalone company dedicated to making APIs
    Lupin launches Ethacrynic Acid Tablets USP, 25 mgLupin launches Ethacrynic Acid Tablets USP, 25 mg
    Gileads drug leads global race to find virus treatmentGilead's drug leads global race to find virus treatment
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X